Search Results

Prospective dosimetry with ^99mTc-MDP in metabolic radiotherapy of bone metastases with ¹⁵³Sm-EDTMP

Authors: Bianchi, L.; Baroli, A.; Marzoli, L.; Verusio, C.; Chiesa, C.; Pozzi, L.

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 36, Number 1, January 2009 , pp. 122-129(8)

Publisher: Springer

Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases

Authors: Lam, Marnix; Dahmane, Amel; Stevens, Wil; Rijk, Peter; Klerk, John; Zonnenberg, Bernard

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 35, Number 4, April 2008 , pp. 756-765(10)

Publisher: Springer

Samarium lexidronam (¹⁵³Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma

Authors: Anderson, Pete; Nuñez, Rodolfo

Source: Expert Review of Anticancer Therapy, Volume 7, Number 11, November 2007 , pp. 1517-1527(11)

Publisher: Expert Reviews

Primary investigation of dose-effect relationship of ¹⁵³Sm-EDTMP in treating multiple bone metastases

Authors: Fan, Wei; Chen, Lixin; Liu, Xiaowei; Tang, Qiang; Zhi, Shengfang; Zeng, Zongyuan

Source: The Chinese-German Journal of Clinical Oncology, Volume 6, Number 4, August 2007 , pp. 396-398(3)

Publisher: Springer

The Use of the Bone Seeking Radiopharmaceutical 153-Samarium-EDTMP as an Adjuvant Treatment for Osteosarcoma: A Review

Author: Stephanie C. Essman,

Source: Current Medical Imaging Reviews, Volume 3, Number 3, August 2007 , pp. 214-218(5)

Publisher: Bentham Science Publishers

Radiopharmaceutical therapy of bone metastases with ⁸⁹SrCl₂, ¹⁸⁶Re-HEDP and ¹⁵³Sm-EDTMP: a dosimetric study using Monte Carlo simulation

Authors: Strigari, L.; Sciuto, R.; D'Andrea, M.; Pasqualoni, R.; Benassi, M.; Maini, C.

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 34, Number 7, July 2007 , pp. 1031-1038(8)

Publisher: Springer

Clinical benefit of bone-targeted radiometabolic therapy with ¹⁵³Sm-EDTMP combined with chemotherapy in patients with metastatic hormone-refractory prostate cancer

Authors: Ricci, Sergio; Boni, Giuseppe; Pastina, Ilaria; Genovesi, Dario; Cianci, Claudia; Chiacchio, Serena; Orlandini, Cinzia; Grosso, Mariano; AlSharif, Abedallatif; Chioni, Aldo; Donato, Samantha; Francesca, Francesco; Selli, Cesare; Rubello, Domenico; Mariani, Giuliano

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 34, Number 7, July 2007 , pp. 1023-1030(8)

Publisher: Springer

Bone Seeking Radiopharmaceuticals for Palliation of Pain in Cancer Patients with Osseous Metastases

Authors: M.G.E.H. Lam,; J.M.H. de Klerk,; P.P. van Rijk,; B.A. Zonnenberg,

Source: Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry, Volume 7, Number 4, July 2007 , pp. 381-397(17)

Publisher: Bentham Science Publishers

Marrow irradiation with high-dose 153Samarium-EDTMP followed by chemotherapy and hematopoietic stem cell infusion for acute myelogenous leukemia

Authors: Rodriguez, Vilmarie; Anderson, Peter; Litzow, Mark; Erlandson, Linda; Trotz, Barbara; Arndt, Carola; Khan, Shakila; Wiseman, Gregory

Source: Leukemia and Lymphoma, Volume 47, Number 8, August 2006 , pp. 1583-1592(10)

Publisher: Informa Healthcare

Samarium for osteoblastic bone metastases and osteosarcoma

Author: Anderson, Pete

Source: Expert Opinion on Pharmacotherapy, Volume 7, Number 11, August 2006 , pp. 1475-1486(12)

Publisher: Informa Healthcare

Low toxicity and efficacy of ¹⁵³samarium-EDTMP and melphalan as a conditioning regimen for secondary acute myelogenous leukemia

Authors: Vilmarie Rodriguez; Linda Erlandson; Carola A. S. Arndt; Gregory A. Wiseman; Peter M. Anderson

Source: Pediatric Transplantation, Volume 9, Number 1, February 2005 , pp. 122-126(5)

Publisher: Blackwell Publishing

¹⁵³Sm-EDTMP for bone pain palliation in skeletal metastases

Authors: Maini, Carlo; Bergomi, Serenella; Romano, Luisa; Sciuto, Rosa

Source: European Journal of Nuclear Medicine and Molecular Imaging, Volume 31, Supplement 1, June 2004 , pp. S171-S178(1)

Publisher: Springer

Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals

Authors: Garnuszek P.; Pawlak D.; Licinska I.; Kaminska A.

Source: Applied Radiation and Isotopes, Volume 58, Number 4, April 2003 , pp. 481-488(8)

Publisher: Elsevier

Evaluation of the 153Sm-EDTMP radiochemical purity using three chromatographic methods

Authors: Gasiglia H.T.; Gonçalves Da silva. C.P.

Source: Journal of Radioanalytical and Nuclear Chemistry, Volume 251, Number 1, January 2002 , pp. 43-46(4)

Publisher: Springer

A Dose-controlled Study of ¹⁵³Sm-Ethylenediaminetetramethylenephosphonate (EDTMP) in the Treatment of Patients with Painful Bone Metastases

Authors: Resche I.; Chatal J.-F.; Pecking A.; Ell P.; Duchesne G.; Rubens R.; Fogelman I.; Houston S.; Fauser A.; Fischer M.; Wilkins D.

Source: European Journal of Cancer, Volume 33, Number 10, September 1997 , pp. 1583-1591(9)

Publisher: Elsevier

Dose response relationship and multiple dose efficacy and toxicity of samarium-153-EDTMP in metastatic cancer to bone

Authors: Alberts A.S.; Smit B.J.; Louw W.K.A.; van Rensburg A.J.; van Beek A.; Kritzinger V.; Nel J.S.

Source: Radiotherapy and Oncology, Volume 43, Number 2, May 1997 , pp. 175-179(5)

Publisher: Elsevier

Nineteen years survival of a case of inoperable small cell lung cancer (SCLS) - A case report

Authors: Ma Y.-Q.; Qin S.-K.; Lu S.-M.; Cha R.-J.

Source: Lung Cancer, Volume 18, Supplement 1, August 1997 , pp. 86-86(1)

Publisher: Elsevier

Evaluation of Samarium-153 and Holmium-166-EDTMP in the Normal Baboon Model

Authors: Louw W.K.A.; Dormehl I.C.; van Rensburg A.J.; Hugo N.; Alberts A.S.; Forsyth O.E.; Beverley G.; Sweetlove M.A.; Marais J.; Lotter M.G.; van Aswegen A.

Source: Nuclear Medicine and Biology, Volume 23, Number 8, November 1996 , pp. 935-940(6)

Publisher: Elsevier